LCI

Lannett Co
NYSE

Real-time Quotes | Nasdaq Last Sale

7.39
-0.31
-4.03%
After Hours: 7.39 0 0.00% 16:00 05/22 EDT
OPEN
7.74
PREV CLOSE
7.70
HIGH
7.74
LOW
7.29
VOLUME
301.13K
TURNOVER
--
52 WEEK HIGH
15.52
52 WEEK LOW
5.16
MARKET CAP
298.19M
P/E (TTM)
-9.0056
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LCI stock price target is 10.25 with a high estimate of 11.00 and a low estimate of 10.00.

EPS

LCI News

More
Edited Transcript of LCI earnings conference call or presentation 6-May-20 8:30pm GMT
Q3 2020 Lannett Company Inc Earnings Call
Thomson Reuters StreetEvents · 11h ago
Is Dr. Reddy's Laboratories a Buy?
MotleyFool.com · 05/10 10:12
Results: Lannett Company, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Simply Wall St. · 05/08 12:28
84 Biggest Movers From Yesterday
Gainers Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shares climbed 78.6% to close at $2.42 on Thursday after falling 10% on Wednesday.
Benzinga · 05/08 09:34
Lannett down after FQ3 earnings miss, guidance cut
Lannett Company (LCI -18.9%) fiscal Q3 results: Net sales: $144.4M (-16.4%). Net loss: ($16.6M) (-256.7%); non-GAAP net income: $11.7M (-56.0%); loss/share
seekingalpha · 05/07 19:25
Why Lannett Company Is Plunging Today
What happened? Shares of Lannett Company (NYSE: LCI) -- a generic drug manufacturer -- are down by 20.3% as of 12:24 p.m. EDT on Thursday. The company released its fiscal third-quarter earnings report after the market closed on Wednesday, and investors were no
Motley Fool · 05/07 17:07
68 Stocks Moving In Thursday's Mid-Day Session
Gainers Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shares jumped 114.4% to $2.9050 after falling 10% on Wednesday.
Benzinga · 05/07 16:42
WMC, TWLO, LCI and LYFT among midday movers
Seeking Alpha - Article · 05/07 16:40

Industry

Pharmaceuticals
-0.29%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About LCI

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
More

Webull offers kinds of Lannett Company, Inc. stock information, including NYSE:LCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCI stock news, and many more online research tools to help you make informed decisions.